Candice Davison Shares a Review on Kell and Kx Blood Group Systems
Candice Davison, Project Research Scientist – Genomics Transfusion Array at Australian Red Cross Lifeblood, shared on LinkedIn:
”Excited to share a recent collaboration with my mentor Dr. Gregory A. Denomme—our review on the Kell (ISBT 006) and Kx (ISBT 019) blood group systems is now published in Immunohematology!
Since 2015, these systems have expanded significantly, with new antigens and alleles registered by ISBT.
Advances in molecular diagnostics are reshaping how we resolve serologic challenges and predict fetal blood type in alloimmunised pregnancies—critical for preventing HDFN.
Anti-K remains a key clinical concern, and emerging technologies like single-cell sequencing and gene editing are opening new doors to understanding red cell biology and immunogenicity.
Davison CL, Denomme GA. Kell and Kx blood group systems: an update. Immunohematology. 2025 Oct 31;41(3):90–99. doi: 10.2478/immunohematology-2025-014
Grateful for the opportunity to learn and contribute alongside a mentor who continues to shape the field!
Your guidance, insight, and generosity Greg, have made this collaboration deeply meaningful.”
Read the abstract here.
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin